Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
The New York Eye & Ear Infirmary Ophtec USA |
---|---|
Information provided by: | The New York Eye & Ear Infirmary |
ClinicalTrials.gov Identifier: | NCT00201604 |
The objective of this study is to determine the safety and effectiveness of Model 311 Iris Reconstruction Lens for the treatment of visual disturbances (glare, halos, photophobia etc.) that are related to the absence of all or part of the human iris.
Condition | Intervention | Phase |
---|---|---|
Photophobia Visual Disturbances |
Device: Model 311 |
Phase III |
Study Type: | Interventional |
Study Design: | Randomized, Open Label, Active Control, Single Group Assignment |
Official Title: | Ophtec Model 311 Iris Reconstruction Lens for the Treatment of Visual Disturbances Resulting From Partial or Total Absence of the Human Iris |
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contact: Kenneth J Rosenthal, M.D | 516-466-8989 | kenrosenthal@eyesurgery.org |
United States, New York | |
Rosenthal Eye and Facial Plastic Surgery | Recruiting |
310 E. Shore Road, Greatneck, New York, United States, 11023 | |
Contact: Kenneth J Rosenthal, M.D 516-466-8989 kenrosenthal@eyesurgery.org |
Principal Investigator: | Kenneth J Rosenthal, M.D | Rosenthal Eye and Facial Plastic Surgery |
Study ID Numbers: | Ophtec USA |
Study First Received: | September 15, 2005 |
Last Updated: | March 21, 2006 |
ClinicalTrials.gov Identifier: | NCT00201604 |
Health Authority: | United States: Food and Drug Administration |
Iris Reconstruction Iris Implant visual disturbances Glare Halos |
Signs and Symptoms Sensation Disorders Vision Disorders |
Eye Diseases Neurologic Manifestations Photophobia |
Nervous System Diseases |